Idan Eisenberg

Impediguide Ltd. develops a platform technology for real time tissue characterization. ImpediGuide's bioimpedance technology provides anesthesiologists and surgeons with intra-operative feedback on the anatomic location of a needle/catheter relative to the epidural space. The EpiDetect, an easy-to-use, cost-effective, novel device is intended to provide real-time guidance to replace the traditional blind-sensing practice. The company was founded in 2007 and is headquartered in Tel Av, Israel.